Detecting sepsis early with blood fluorescence
Part of Infections clinical trials.
This trial uses a blood fluorescence test to check for early signs of sepsis. It may help doctors diagnose sepsis faster, allowing for quicker treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy volunteers: you must be generally healthy and not hospitalized in the last 2 years.
- Sepsis group: you must have a confirmed infection and a qSOFA score of 2 or higher plus a SOFA score of 2 or higher.
- Non-septic severe group: you must have a suspected or confirmed infection and a SOFA score of 1.
- You must be an adult (not a minor), not pregnant, and without a mental illness.
- Your doctor will confirm if you meet the criteria for the group you are in.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to detect sepsis using fluorescence from a blood sample. It may help doctors identify sepsis earlier and improve treatment.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.